TD Asset Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,056
Closed -$803K 1522
2021
Q1
$803K Buy
2,056
+501
+32% +$247K ﹤0.01% 1306
2020
Q4
$871K Buy
1,555
+190
+14% +$120K ﹤0.01% 1212
2020
Q3
$954K Sell
1,365
-1,034
-43% -$806K ﹤0.01% 1091
2020
Q2
$1.9M Buy
2,399
+361
+18% +$272K ﹤0.01% 889
2020
Q1
$1.21M Sell
2,038
-656
-24% -$639K ﹤0.01% 953
2019
Q4
$3.06M Buy
2,694
+3
+0.1% +$3.26K ﹤0.01% 827
2019
Q3
$3.2M Sell
2,691
-293
-10% -$447K ﹤0.01% 794
2019
Q2
$4.92M Sell
2,984
-341
-10% -$590K 0.01% 689
2019
Q1
$6.78M Buy
3,325
+315
+10% +$555K 0.01% 620
2018
Q4
$3.87M Sell
3,010
-933
-24% -$1.43M 0.01% 739
2018
Q3
$7.46M Buy
3,943
+15
+0.4% +$31K 0.01% 614
2018
Q2
$7.99M Buy
3,928
+285
+8% +$650K 0.01% 572
2018
Q1
$8.06M Buy
3,643
+240
+7% +$610K 0.01% 566
2017
Q4
$7.85M Buy
3,403
+169
+5% +$343K 0.01% 574
2017
Q3
$5.75M Sell
3,234
-262
-7% -$366K 0.01% 629
2017
Q2
$4.76M Sell
3,496
-579
-14% -$699K 0.01% 684
2017
Q1
$4.8M Sell
4,075
-520
-11% -$530K 0.01% 700
2016
Q4
$3.67M Buy
4,595
+21
+0.5% +$16.7K 0.01% 744
2016
Q3
$4.02M Buy
4,574
+1,393
+44% +$1.01M 0.01% 744
2016
Q2
$1.78M Sell
3,181
-23
-0.7% -$13K ﹤0.01% 867
2016
Q1
$1.76M Sell
3,204
-139
-4% -$85.4K ﹤0.01% 862
2015
Q4
$2.78M Sell
3,343
-69
-2% -$68.9K 0.01% 783
2015
Q3
$3.78M Buy
3,412
+154
+5% +$281K 0.01% 707
2015
Q2
$7.11M Sell
3,258
-69
-2% -$141K 0.01% 592
2015
Q1
$5.21M Buy
3,327
+586
+21% +$773K 0.01% 652
2014
Q4
$3.26M Buy
2,741
+1,097
+67% +$733K 0.01% 765
2014
Q3
$764K Buy
+1,644
New +$759K ﹤0.01% 952

Other funds holding BLUE

TD Asset Management's BLUE Position: Q2 2021 in Review

TD Asset Management sold out of bluebird bio (BLUE) in Q2 2021, closing a stake of 2,056 shares — an estimated $803K sold.

TD Asset Management first reported a position in BLUE in Q3 2014 and held it in 27 quarters. The position peaked at $8.06M in Q1 2018. 232 funds tracked by Wall St. Rank hold BLUE as of Q2 2021.

  • TD Asset Management reported no remaining bluebird bio position as of Q2 2021 after selling out during the quarter.
  • TD Asset Management sold 2,056 bluebird bio shares in Q2 2021, an estimated $803K.
  • TD Asset Management first reported a position in bluebird bio in Q3 2014 and held it in 27 quarters.
  • TD Asset Management's bluebird bio position peaked at $8.06M in Q1 2018.
  • 232 funds tracked by Wall St. Rank held bluebird bio as of Q2 2021.

Based on TD Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.